Patent · US Expired

7-acylamino-3-heteroarylthio-3-cephem carboxylic acid antibiotics and prodrugs thereof

US6723716B1 · kind B1 · utility

1Cited by
6References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 21, 2000
Grant dateApr 20, 2004
Priority date
Expiry dateSep 21, 2020

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07F9/6506
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention relates to a cephem prodrug having formula III or formula IV: or a pharmaceutically acceptable salt thereof, wherein R′1 is selected from the group consisting of hydrogen and —C(O)CH(NH2)CH3 and R′2 is selected from the group consisting of hydrogen and an acyl group that is cleaved by an enzyme found in mammals, with the proviso that, when either R′1 or R′2 is hydrogen, the other is not. A, B, L, G, E, and J are each independently nitrogen or carbon such that the respective rings are selected from the group consisting of provided that the group —CH2—S—CH2CH2NHR′2 is attached only to a carbon atom of said heterocyclic group, and Q is selected from the group consisting of nitrogen and —CX, wherein X is selected from the group consisting of hydrogen and chlorine.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.